Last update 16 May 2024

Rovazolac

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Rovazolac (USAN)
Target
LXR
Mechanism
LXR agonists(Liver X receptor agonists)
Therapeutic Areas
Immune System DiseasesCongenital DisordersSkin and Musculoskeletal Diseases
Active Indication-
Inactive Indication
Dermatitis, AtopicEczema
Originator Organization
Alexar Therapeutics, Inc.Alexar Therapeutics, Inc.
Active Organization-
Inactive Organization
Alexar Therapeutics, Inc.Alexar Therapeutics, Inc.Ralexar Therapeutics, Inc.
Drug Highest PhasePendingPhase 2
First Approval Date-
Regulation-

Structure

Molecular FormulaC21H19F3N2O4S
InChIKeyZUMNJDGBYXHASJ-UHFFFAOYSA-N
CAS Registry1454288-88-0

Related

2
Clinical Trials associated with Rovazolac
NCT03859986 / Unknown statusPhase 2
A Phase 2, Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study To Evaluate The Safety And Efficacy Of ALX-101 Topical Gel Administered Twice Daily In Adult And Adolescent Subjects With Moderate Atopic Dermatitis
NCT03175354 / CompletedPhase 2
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
100 Clinical Results associated with Rovazolac
Login to view more data
100 Translational Medicine associated with Rovazolac
Login to view more data
100 Patents (Medical) associated with Rovazolac
Login to view more data
100 Deals associated with Rovazolac
Login to view more data

External Link

KEGGWikiATCDrug Bank
D11327--
DB16320

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
EczemaPhase 2
CA
Alexar Therapeutics, Inc.Alexar Therapeutics, Inc.
08 Mar 2019
EczemaPhase 2
US
Alexar Therapeutics, Inc.Alexar Therapeutics, Inc.
08 Mar 2019
Dermatitis, AtopicPhase 2
US
Ralexar Therapeutics, Inc.
26 Apr 2017
Dermatitis, AtopicPhase 2
US
Alexar Therapeutics, Inc.Alexar Therapeutics, Inc.
26 Apr 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free